Bookmark
Forward
The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.
E Matutes, A G Bosanquet, R Wade, S M Richards, M Else, D Catovsky
Leukemia 2013 FebSizes of these terms reflect their relevance to your search.
No abstract available.
Citation
E Matutes, A G Bosanquet, R Wade, S M Richards, M Else, D Catovsky. The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry. Leukemia. 2013 Feb;27(2):507-10
Mesh Tags
Substances
PMID: 22810506
View Full Text
